The rotator-cuff moment
A few years back, training for a triathlon, I tore my rotator cuff. The orthopedist's menu was the usual one - cortisone shot, or surgery. Neither felt right. I'd been an athlete my whole life (swimming, running, lifting, whatever was in season) and was looking at being benched for months.
So I did what curious people do at 11pm with a sore shoulder. I started reading. Somewhere in a PubMed rabbit hole I landed on BPC-157. Talked to a doctor who actually knew the compound. Ran a 4-week protocol. Got back in training. The shoulder held.
That was the moment peptides stopped feeling fringe and started feeling like a category that was just under-covered. Not magic. Not snake oil. Real research the average adult has no clean way to find. And once I went looking, the pattern was obvious: the most interesting compounds in medicine are the ones big pharma can't patent. Peptides do not fit the patent-then-charge-20-grand-a-month model, so they do not get pushed. Insurance will not cover them. Most doctors do not prescribe them. The compounding pharmacies that do sell them live under constant regulatory threat. Meanwhile the studies keep landing.
Why this exists
Search "peptides" right now. You get three flavors: Reddit threads full of pseudonyms arguing dosing, biohacker podcasters talking about their personal "stack," and Instagram accounts trying to sell you one. The actual middle - plain-English reference content grounded in the studies - barely exists.
Meanwhile, ordinary people are weighing real decisions. Whether to switch from Ozempic to Mounjaro. Whether BPC-157 is worth trying for a stubborn tendon. Whether the GLP-1 their sister is on is the right one for them. Those decisions deserve better than a Reddit thread.
Protocol One is the missing middle. Researched against primary literature. Written for adults who didn't go to med school. Ranked honestly on what's working versus what's hype.
Who I am
I'm Bill. I live in Nashville, Tennessee. Lifelong athlete - triathlon, swimming, lifting, running, never not training for something. The kind of person who would rather get in the arena and get knocked around than sit it out. Life is too interesting to spend on the sidelines, and the human body is too good a piece of equipment to let depreciate without a fight. BPC-157 is the only peptide I currently take, as part of a Restore Protocol that got me back in training after the rotator-cuff tear. Everything I write here, I would want a friend to read before they made the same call.
Who I'm writing for
Honestly? My dad.
He's getting older. Still trains, still wants to stay in the game, still cares about being mobile and sharp for the next 20 years. Peptides and longevity protocols are exactly the category that could help him - and exactly the category that's drowning in Reddit pseudonyms, podcasters with coupon codes, and Instagram accounts selling stacks.
I started writing this so he'd have one clean place to read. Plain English, real research, honest about what's working and what's hype. If you're his age, or you're someone's son or daughter trying to figure this out on their behalf, you're who this is for.
Every page, I'm asking the same question: would my dad understand this? Would he trust it? Would I want him running this protocol? That's the bar.
What Protocol One is not
- Not written by a doctor. I have no medical degree, no clinical practice, no license to prescribe anything.
- Not medical advice. Nothing here replaces a conversation with your physician.
- Not a proprietary protocol or stack I'm selling you. There's no "Protocol One Premium." There's no $497 course.
- Not pretending to have all the answers. Where the evidence is thin, I say so.
What we do
- Plain-English reference entries for 17 peptides, with more added as research warrants.
- A weekly dispatch newsletter every Tuesday at 6:30am ET. Free. About 5 minutes to read.
- Editorial dosing protocols tied to the source studies, not Reddit folklore.
- Honest vendor recommendations, with affiliate relationships disclosed in plain view.
- "Working vs hype" framing on every peptide, so you can tell signal from noise.
How we make money
The newsletter is free and always will be. When we recommend a vendor (a telehealth provider for GLP-1s, a compounding pharmacy for BPC-157, a topical product for GHK-Cu), we sometimes earn a commission if you sign up through our link. That's labeled.
The rule we hold ourselves to: we only recommend products we'd use ourselves, or send a friend to. If something underperforms, we update the entry. If a vendor relationship gets sketchy, we drop them and say why. Editorial independence is the whole business model. If you can't trust the recommendation, the affiliate link is worthless anyway.
Contact
Questions, corrections, a study I should be reading, a peptide that deserves an entry - hello@readprotocolone.com. I read every email. If you reply to a dispatch, that goes to the same place.